Research Grants 15,986 show all


$157M
2015

$175.5M
2016

$188.1M
2017

$183.5M
2018

$43.1M
2019

Patents 3,010show all

  • 1,425
    A61K - Preparations for medical, dental, or toilet purposes
  • 761
    C07K - Peptides
  • 569
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 562
    C12N - Microorganisms or enzymes
  • 247
    Y02A - Technologies for adaptation to climate change
  • 209
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 190
    A61B - Diagnosis
  • 144
    C07D - Heterocyclic compounds
  • 139
    C07C - Acyclic or carbocyclic compounds
  • 90
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Publications 2,013 show all

  • 33
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 30
    Lung Neoplasms/drug therapy
  • 25
    Carcinoma, Non-Small-Cell Lung/drug therapy
  • 21
    Antineoplastic Agents/pharmacology
  • 16
    Leukemia, Myeloid, Acute/drug therapy
  • 13
    Antineoplastic Agents/therapeutic use
  • 13
    Drug Approval
  • 12
    Attitude of Health Personnel
  • 12
    Breast Neoplasms/drug therapy
  • 12
    Calcium/metabolism

Clinical Trials 536show all

167Phase 3159Phase 253N/A47Phase 127Phase 1/Phase 232Other

Contact Information

Baltimore, MD
United States